1-(carboxymethylthio)tetradecane has been researched along with HIV Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aukrust, P; Berge, RK; Bohov, P; Dyrøy, E; Fredriksen, J; Frøland, SS; Halvorsen, B; Melby, K; Melbye, L; Skalhegg, BS; Skorve, J; Ueland, T | 1 |
1 other study(ies) available for 1-(carboxymethylthio)tetradecane and HIV Infections
Article | Year |
---|---|
Lipid-lowering and anti-inflammatory effects of tetradecylthioacetic acid in HIV-infected patients on highly active antiretroviral therapy.
Topics: Adult; Animals; Anti-Inflammatory Agents; Female; HIV Infections; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Leukocytes, Mononuclear; Lipids; Male; Mice; Middle Aged; Pilot Projects; Receptors, Immunologic; Receptors, Scavenger; Reverse Transcriptase Polymerase Chain Reaction; Sulfides; Up-Regulation | 2004 |